Wishing former RPRD student intern Megan Mills, PharmD congratulations as she moves to the next phase as clinical oncology pharmacists at @Froedtert Hospital! https://t.co/dWVR4P64nP
We are saddened to learn of @oneome's closure and want to acknowledge the company’s meaningful contributions to advancing pharmacogenomics and precision medicine. We recognize the dedication of the talented professionals who contributed to moving the industry forward.
Are you in Missoula @pgrnhub? Please pay our very own Amy Turner a visit tonight as she presents CYP2C19 c.681G>A Is Not in Complete Linkage With c.332–23A>G: Implications for Pharmacogenetic Testing, from 5:30p-7:30p MT.
RPRD's 2nd @pgrnhub Travel Award winner is Madison Shotton, a PharmD Candidate (Class of 2026) @KUPharmacy. She will present her research, Assessing the Potential Pharmacogenomic Guideline Usage in an Outpatient Hospital Pharmacy, at PGRN. Congrats!
It's @pgrnhub week, and we're excited to introduce the first winner of an RPRD sponsored Travel Award! Tayler B. Smith is a fourth-year PhD candidate in Medical and Molecular Genetics at the @IUScholars, where she studies pharmacogenomics. Congrats Tayler!
RPRD had an amazing afternoon hosting Friends of MCW for a PGx fireside chat with our very own Dr. Broeckel, and @MCWPharmacy's Dean MacKinnon. We deeply value our relationship with the School, and the opportunities it provides to spread the #PrecisionMedicine message.
We are pleased to inform you our paper “New Resources to Identify Characterized DNA Reference Materials for PGx and HLA Testing...” has been published. https://t.co/5nSJUF9SE2
@RPRDx values the relationship with @MCWPharmacy and being a participating entity in their rotation program. We look forward to welcoming 2 new students in October!
Sage Orlowski, a 2025 #PharmD candidate, aspires to become a solid organ transplant pharmacist, a field which utilizes #PersonalizedMedicine. Our Office of Experiential Education paired her with a rotation with RPRD Diagnostics. https://t.co/ii0VJ8J396
#Pharmacogenomics@RPRDx
@AllofUsResearch highlights collaboration with @RPRDx on our discovery of novel DYPD haplotypes and implications leading to updated guidelines for pharmacogenomic testing, https://t.co/d504V0P8iZ.
Congrats to @RPRDx Travel Award Winner to attend @pgrnhub 9/23-9/25 @yuting_shan. Yuting is a PharmD Candidate at @UMN_Pharmacy, focusing on cancer research.
Congrats to @RPRDx Travel Award Winner to attend @pgrnhub 9/23-9/25, Shayna Killam. Shayna is a Postdoc at the L.S. Skaggs Institute for Health Innovation @umontana, and studies pharmacogenetic implementation in rural and underserved settings. #PrecisionMedicine#PGx
We are pleased to inform you our paper “Characterization of Reference Materials for DPYD: A GeT-RM Collaborative Project” has been published. https://t.co/bfL7YziVK8 #precisionmedicine#pharmacogenomics
We are pleased to inform you our paper “DPYD Genotyping Recommendations: A Joint Consensus Recommendation” has been published. https://t.co/OdgVXIYV2T #precisionmedicine#pharmacogenomics
Congratulations to our Interdisciplinary Colleague of the Year award winners from RPRD Diagnostics (@RPRDx)
- Amy Turner, MS - Director of Operations and Innovation
- Ashley Derezinski, BS - Clinical Lab Supervisor
Sage Orlowski, Pharm D Candidate at @MCWPharmacy, will be presenting a paper on a SNP in NFIB and CYP2D6-catalyzed metabolism in Journal Club tomorrow at 1p CT. DM to join. #journalclub#precisionmedicine
Journal Club tomorrow @ 1p CT, with RPRD's very own Jason Oliva presenting "RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy". DM to join. #rprd#journalclub#precisionmedicine